| Ident. | Authors (with country if any) | Title |
|---|
| 000033 (2021) |
Dania Altulea [Pays-Bas] ; Sjors Maassen [Pays-Bas] ; Maksim V. Baranov [Pays-Bas] ; Geert Van Den Bogaart [Pays-Bas] | What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology. |
| 000062 (2021) |
Mohamed A. Taha [États-Unis, Égypte] ; Christian A. Hall [États-Unis] ; Colin J. Shortess [États-Unis] ; Richard F. Rathbone [États-Unis] ; Henry P. Barham [États-Unis] | Treatment Protocol for COVID-19 Based on T2R Phenotype. |
| 000065 (2021) |
Guobing Li [République populaire de Chine, États-Unis] ; Shasha Ruan [République populaire de Chine] ; Xiaolu Zhao [République populaire de Chine] ; Qi Liu [États-Unis] ; Yali Dou [États-Unis] ; Fengbiao Mao [République populaire de Chine] | Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses. |
| 000069 (2021) |
Waqas Aslam [Oman] ; Carla R. Lamb [États-Unis] ; Nadia Ali [États-Unis] | Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications. |
| 000083 (2021) |
Nurdan Kokturk [Turquie] ; Cenk Babayigit [Turquie] ; Seval Kul [Turquie] ; Pelin Duru Cetinkaya [Turquie] ; Sibel Atis Nayci [Turquie] ; Serap Argun Baris [Turquie] ; Oguz Karcioglu [Turquie] ; Pinar Aysert [Turquie] ; Ilim Irmak [Turquie] ; Aycan Akbas Yuksel [Turquie] ; Yonca Sekibag [Turquie] ; Oya Baydar Toprak [Turquie] ; Emel Azak [Oman] ; Sait Mulamahmutoglu [Turquie] ; Caglar Cuhadaroglu [Turquie] ; Aslihan Demirel [Turquie] ; Bugra Kerget [Turquie] ; Burcu Baran Ketencioglu [Turquie] ; Hasan Selcuk Ozger [Turquie] ; Gulcihan Ozkan [Turquie] ; Zeynep Ture [Turquie] ; Begum Ergan [Turquie] ; Vildan Avkan Oguz [Turquie] ; Oguz Kilinc [Turquie] ; Merve Ercelik [Turquie] ; Tansu Ulukavak Ciftci [Turquie] ; Ozlem Alici [Turquie] ; Esra Nurlu Temel [Turquie] ; Ozlem Ataoglu [Turquie] ; Asena Aydin [Turquie] ; Dilek Cetiner Bahcetepe [Turquie] ; Yusuf Taha Gullu [Turquie] ; Fusun Fakili [Turquie] ; Figen Deveci [Turquie] ; Neslihan Kose [Turquie] ; Muge Meltem Tor [Turquie] ; Gulsah Gunluoglu [Turquie] ; Sedat Altin [Turquie] ; Teyfik Turgut [Turquie] ; Tibel Tuna [Turquie] ; Onder Ozturk [Turquie] ; Oner Dikensoy [Turquie] ; Pinar Yildiz Gulhan [Turquie] ; Ilknur Basyigit [Turquie] ; Hasim Boyaci [Turquie] ; I Kivilcim Oguzulgen [Turquie] ; Sermin Borekci [Turquie] ; Bilun Gemicioglu [Turquie] ; Firat Bayraktar [Turquie] ; Osman Elbek [Turquie] ; Ismail Hanta [Turquie] ; Hacer Kuzu Okur [Turquie] ; Gulseren Sagcan [Turquie] ; Oguz Uzun [Turquie] ; Metin Akgun [Turquie] ; Goksel Altinisik [Turquie] ; Berna Dursun [Turquie] ; Ebru Cakir Edis [Turquie] ; Erkmen Gulhan [Turquie] ; Fusun Oner Eyuboglu [Turquie] ; Okkes Gultekin [Turquie] ; Yavuz Havlucu [Turquie] ; Metin Ozkan [Turquie] ; Aysin Sakar Coskun [Turquie] ; Abdullah Sayiner [Turquie] ; Ali Fuat Kalyoncu [Turquie] ; Oya Itil [Turquie] ; Hasan Bayram [Turquie] | The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. |
| 000125 (2021) |
Andy Sing Ong Tang ; Tze Shin Leong ; Lee Ping Chew ; Hock Hin Chua | Successful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report. |
| 000127 (2021) |
Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar] | Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2. |
| 000129 (2021) |
Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde] | Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies. |
| 000148 (2021) |
Jean Franco Quispe-Ca Ari [Pérou] ; Evelyn Fidel-Rosales [Pérou] ; Diego Manrique [Pérou] ; Jesús Mascar Zan [Pérou] ; Katia Medalith Huamán-Castill N [Pérou] ; Scherlli E. Chamorro-Espinoza [Pérou] ; Humberto Garayar-Peceros [Pérou] ; Vania L. Ponce-L Pez [Pérou] ; Jhesly Sifuentes-Rosales [Pérou] ; Aldo Alvarez-Risco [Pérou] ; Jaime A. Yá Ez [Pérou] ; Christian R. Mejia [Pérou] | Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. |
| 000163 (2021) |
Tanvir Rahman [États-Unis] ; Quazim A. Alayo [États-Unis] ; Sibgha G. Chaudhary [États-Unis] ; Reihaneh C. Moghadam [États-Unis] ; Matthew L. German [États-Unis] ; Neil A. Ettinger [États-Unis] ; Jeremy E. Leidenfrost [États-Unis] ; Hope A. Cranston-D'Amato [États-Unis] ; Morton R. Rinder [États-Unis] ; Julianne E. Donnelly [États-Unis] | STEMI associated with SARS-CoV-2 infection and the use of ECMO as a potential therapeutic approach in addition to the PCI. |
| 000183 (2021) |
Byung Jin Choi [Corée du Sud] ; Yeryung Koo [Corée du Sud] ; Tae Young Kim [Corée du Sud] ; Wou Young Chung [Corée du Sud] ; Yun Jung Jung [Corée du Sud] ; Ji Eun Park [Corée du Sud] ; Hong-Seok Lim [Corée du Sud] ; Bumhee Park [Corée du Sud] ; Dukyong Yoon [Corée du Sud] | Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice. |
| 000214 (2021) |
Ranadheer Dande [États-Unis] ; Anum Qureshi [États-Unis] ; Kia Persaud [États-Unis] ; Chahat Puri [États-Unis] ; Sajida Zulfiqar [États-Unis] ; Shankar Awasthi [États-Unis] | Remdesivir in a pregnant patient with COVID-19 pneumonia. |
| 000231 (2021) |
Venkata R. Emani [États-Unis] ; Sanjeev Goswami [États-Unis] ; Dheeraj Nandanoor [États-Unis] ; Shaila R. Emani [États-Unis] ; Nidhi K. Reddy [États-Unis] ; Raghunath Reddy [États-Unis] | Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs. |
| 000232 (2021) |
Maximilian Gro E [Allemagne] ; Natalia Ruetalo [Allemagne] ; Mirjam Layer [Allemagne] ; Dan Hu [Allemagne] ; Ramona Businger [Allemagne] ; Sascha Rheber [Allemagne] ; Christian Setz [Allemagne] ; Pia Rauch [Allemagne] ; Janina Auth [Allemagne] ; Maria Fröba [Allemagne] ; Ekkehard Brysch [Allemagne] ; Michael Schindler [Allemagne] ; Ulrich Schubert [Allemagne] | Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. |
| 000233 (2021) |
Olfa Noureddine [Tunisie] ; Noureddine Issaoui [Tunisie] ; Mouna Medimagh [Tunisie] ; Omar Al-Dossary [Arabie saoudite] ; Houda Marouani [Tunisie] | Quantum chemical studies on molecular structure, AIM, ELF, RDG and antiviral activities of hybrid hydroxychloroquine in the treatment of COVID-19: Molecular docking and DFT calculations. |
| 000249 (2021) |
Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine] | Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. |
| 000271 (2021) |
Ahmed A. Ishola [Nigeria] ; Kayode E. Adewole [Nigeria] ; Habibu Tijjani [Nigeria] ; Suliat I. Abdulai [Nigeria] ; Nnaemeka T. Asogwa [Nigeria] | Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs. |
| 000292 (2021) |
Hesham Refaat [Égypte] ; Fatma M. Mady [Égypte] ; Hatem A. Sarhan [Égypte] ; Heba S. Rateb [Égypte] ; Eman Alaaeldin [Égypte] | Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. |
| 000332 (2021) |
R K Hussein [Arabie saoudite] ; H M Elkhair [Arabie saoudite, Soudan] | Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19. |
| 000341 (2021) |
Kaho Shionoya [Japon] ; Masako Yamasaki [Japon] ; Shoya Iwanami [Japon] ; Yusuke Ito [Japon] ; Shuetsu Fukushi [Japon] ; Hirofumi Ohashi [Japon] ; Wakana Saso [Japon] ; Tomohiro Tanaka [Japon] ; Shin Aoki [Japon] ; Kouji Kuramochi [Japon] ; Shingo Iwami [Japon] ; Yoshimasa Takahashi [Japon] ; Tadaki Suzuki [Japon] ; Masamichi Muramatsu [Japon] ; Makoto Takeda [Japon] ; Takaji Wakita [Japon] ; Koichi Watashi [Japon] | Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. |
| 000396 (2021) |
Agata Blasiak ; Jhin Jieh Lim ; Shirley Gek Kheng Seah ; Theodore Kee ; Alexandria Remus ; De Hoe Chye ; Pui San Wong ; Lissa Hooi ; Anh T L. Truong ; Nguyen Le ; Conrad E Z. Chan ; Rishi Desai ; Xianting Ding ; Brendon J. Hanson ; Edward Kai-Hua Chow ; Dean Ho | IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. |
